NEW ENTERPRISE ASSOCIATES 16, L.P. (MARKER THERAPEUTICS) - SCHEDULE 13DA1

Company

Marker Therapeutics, Inc.

Filed

March 26, 2021

Accession Number

0001072613-21-000318